USPTO serial 78072521
ANGIOTECH PHARMACEUTICALS
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- WOOD, CAROLINE
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ANGIOTECH PHARMACEUTICALS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kevin S. C ostanza
KEVIN S COSTANZA SEED IP LAW GROUP PLLC701 FIFTH AVE STE 6300SEATTLE, WA 98104-7092UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | medical stents; opthalmologic implants comprised of artificial material; orthopedic implants comprised of artificial material; otolaryngology implants comprised of artificial material; plastic surgery implants comprised of artificial material; genitourinary implants comprised of artificial material; gastrointestinal implants comprised of artificial material; dural implants comprised of artificial material; neurological implants comprised of artificial material; medical shunts; neurological shunts; cardiovascular catheters; gastrointestinal catheters; genitourinary catheters; cardiovascular grafts; surgical adhesions barriers; cardiovascular infusion lines; cardiovascular ports; angioplasty balloons; vascular wraps; and dural patches | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Angiotech Pharmaceuticals, Inc.
- Other trademarks owned by Angiotech Pharmaceuticals, Inc.
- Other trademarks in Class 010
- Similar marks named ANGIOTECH PHARMACEUTICALS
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 28, 2005 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Dec 28, 2005 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Apr 13, 2005 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Apr 13, 2005 | EXT5 | SOU EXTENSION 5 FILED | — |
| Apr 13, 2005 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 1, 2004 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Oct 21, 2004 | EXT4 | SOU EXTENSION 4 FILED | — |
| Oct 21, 2004 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 30, 2004 | CFIT | CASE FILE IN TICRS | — |
| Jul 14, 2004 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 19, 2004 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Feb 4, 2004 | EXT3 | SOU EXTENSION 3 FILED | — |
| Feb 4, 2004 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 20, 2003 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Oct 13, 2003 | EXT2 | SOU EXTENSION 2 FILED | — |
| Oct 13, 2003 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 30, 2003 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 22, 2003 | EXT1 | SOU EXTENSION 1 FILED | — |
| Apr 22, 2003 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 22, 2002 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 15, 2002 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 30, 2002 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 10, 2002 | NPUB | NOTICE OF PUBLICATION | — |
| May 8, 2002 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 15, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 21, 2001 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 11, 2001 | DOCK | ASSIGNED TO EXAMINER | — |